Bank of New York Mellon’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $4.63K | Hold |
|
|||||
|
2023
Q3 | $6.3K | Sell |
|
|||||
|
2023
Q2 | $35K | Sell |
|
|||||
|
2023
Q1 | $146K | Buy |
|
|||||
|
2022
Q4 | $159K | Sell |
|
|||||
|
2022
Q3 | $1.04M | Buy |
|
|||||
|
2022
Q2 | $739K | Sell |
|
|||||
|
2022
Q1 | $1M | Sell |
|
|||||
|
2021
Q4 | $656K | Buy |
|
|||||
|
2021
Q3 | $833K | Buy |
|
|||||
|
2021
Q2 | $984K | Buy |
|
|||||
|
2021
Q1 | $919K | Sell |
|
|||||
|
2020
Q4 | $1.28M | Buy |
|
|||||
|
2020
Q3 | $768K | Buy |
|
|||||
|
2020
Q2 | $879K | Buy |
|
|||||
|
2020
Q1 | $522K | Buy |
|
|||||
|
2019
Q4 | $1.13M | Buy |
|
|||||
|
2019
Q3 | $761K | Buy |
|
|||||
|
2019
Q2 | $770K | Buy |
|
|||||
|
2019
Q1 | $329K | Buy |
|
|||||
|
2018
Q4 | $200K | Sell |
|
|||||
|
2018
Q3 | $239K | Sell |
|
|||||
|
2018
Q2 | $249K | Buy |
|
|||||
|
2018
Q1 | $147K | Buy |
|
|||||
|
2017
Q4 | $199K | Sell |
|
|||||
|
2017
Q3 | $160K | Hold |
|
|||||
|
2017
Q2 | $115K | Buy |
|
|||||
|
2017
Q1 | $157K | Buy |
|
|||||
|
2016
Q4 | $152K | Buy |
|
|||||
|
2016
Q3 | $165K | Buy |
|
|||||
|
2016
Q2 | $214K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $91K | Hold |
|
|||||
|
2015
Q3 | $65K | Hold |
|
|||||
|
2015
Q2 | $78K | Sell |
|
|||||
|
2015
Q1 | $1.46M | Buy |
|
|||||
|
2014
Q4 | $1.17M | Buy |
|
|||||
|
2014
Q3 | $573K | Hold |
|
|||||
|
2014
Q2 | $879K | Buy |
|
|||||
|
2014
Q1 | $170K | Buy |
|